BioCentury | Oct 6, 2016
Distillery Therapeutics

Therapeutics: Motor neuron and pancreas homeobox 1 (MNX1)

...Cancer INDICATION: Prostate cancer In vitro and mouse studies suggest inhibiting MNX1 could help treat prostate...
...could help treat prostate cancer in African-American men. In tissue samples from prostate cancer patients, MNX1...
...cancer, MNX1 knockdown decreased tumor growth. Next steps could include developing an MNX1 inhibitor. TARGET/MARKER/PATHWAY: Motor neuron and pancreas homeobox 1 (MNX1)...
BioCentury | Sep 29, 1997
Finance

Raab promises blockbuster IPO

Ebb & Flow Raab promises blockbuster IPO Sinogen International, a Chinese manufacturer and distributor of alpha interferon, is looking to do an IPO next year, according to Chairman Kirk Raab, who warns investors to brace...
Items per page:
1 - 2 of 2